Nuala Calnan

Nuala Calnan, PhD, serves as a Member of the Board of Advisors at Blynksolve since January 2024 and is the Founder of The Quality Risk Management Institute, which aims to enhance patient safety in the biopharma industry through effective Quality Risk Management. Nuala holds the position of CEO at BioPharm Excel, focusing on driving innovation and quality excellence in biopharmaceuticals. Additionally, Nuala is the Arnold F. Graves Scholar at TU Dublin, conducting post-doctoral research to improve QRM practices, and an Adjunct Research Fellow in Regulatory Science at Dublin Institute of Technology, leading various research projects in pharmaceutical regulatory science. Previous roles include Senior Associate at Lachman Consultant Services, Regulatory Science Researcher and PhD Candidate at Dublin Institute of Technology, Principal Consultant at PM Group, and project management positions at Pfizer and Elan. Nuala's academic credentials include a PhD in Pharmaceutical Regulatory Science and an MBA in Business Administration, Strategy, and Innovation.